Zanthera Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Secunderabad, Telangana, India, established in 2007.
2007 Secunderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Zanthera Pharmaceuticals Private Limited

Zanthera Pharmaceuticals Private Limited, a struck off private limited company, was established on 08 August 2007 in Secunderabad, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232TG2007PTC055074. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M.

Its leadership includes Swaroopkumar Venkata Satya Vakkalanka (Managing Director), Satya Kameswari Vakkalanka (Director). Past directors included Swaroopkumar Venkata Satya Vakkalanka, Krishna Rao Vakkalanka, Milind Arunkumar Antani. It is based at H.No: 27, Rukminidevi Colony, Phase - Ii Opp. Aoc Centre, West Marredpally, Secunderabad, Telangana, 500026.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2007PTC055074

  • Registration Number

    055074

  • Incorporation Date

    08 August 2007

  • Authorized Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Company Age 18 Year, 9 Months
Company report

Zanthera Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Zanthera Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Zanthera Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Swaroopkumar Venkata Satya Vakkalanka Managing Director 02 Jan 2008 Current
Satya Kameswari Vakkalanka Director 08 Aug 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 06 Feb 2008 Past
Pramod Abcsdd Additional Director 06 Feb 2008 Past
Pramod Abcsdd Director 30 Aug 2007 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zanthera Pharmaceuticals.

Enhance accessibility to Zanthera Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Zanthera Pharmaceuticals revenue growth over time
Zanthera Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zanthera Pharmaceuticals?

Unlock access to Zanthera Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Zanthera Pharmaceuticals?

Unlock and access historical data on people associated with Zanthera Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Zanthera Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zanthera Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zanthera Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Swaroopkumar Venkata Satya Vakkalanka was appointed as a Managing Director was appointed as a Managing Director on 02 Jan 2008 & has been associated with this company since 18 years 4 months . was documented.

  • Director Appointment

    Progress on Satya Kameswari Vakkalanka was appointed as a Director was appointed as a Director on 08 Aug 2007 & has been associated with this company since 18 years 9 months . was documented.

  • Company Incorporation

    The activity Zanthera Pharmaceuticals Private Limited was registered on 08 Aug 2007 with Roc Hyderabad & aged 18 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Zanthera Pharmaceuticals Private Limited?

The CIN of Zanthera Pharmaceuticals Private Limited is U24232TG2007PTC055074.

Where is Zanthera Pharmaceuticals Private Limited headquartered?

Zanthera Pharmaceuticals Private Limited is headquartered at H.No: 27, Rukminidevi Colony, Phase - Ii Opp. Aoc Centre, West Marredpally, Secunderabad, Telangana, 500026.

When was Zanthera Pharmaceuticals Private Limited incorporated?

Zanthera Pharmaceuticals Private Limited was incorporated on 08 August 2007.

Who are the current directors of Zanthera Pharmaceuticals Private Limited?

The current directors of Zanthera Pharmaceuticals Private Limited are

What is the primary industry of Zanthera Pharmaceuticals Private Limited?

The primary industry of Zanthera Pharmaceuticals Private Limited is Chemicals.

Is Zanthera Pharmaceuticals Private Limited a listed company?

Zanthera Pharmaceuticals Private Limited is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available